{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:10:13Z","timestamp":1780629013922,"version":"3.54.1"},"reference-count":38,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1428,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1365-2265.2011.04106.x","type":"journal-article","created":{"date-parts":[[2011,5,16]],"date-time":"2011-05-16T22:41:26Z","timestamp":1305585686000},"page":"678-684","source":"Crossref","is-referenced-by-count":25,"title":["Comparison of primary octreotide-lar and surgical treatment in newly diagnosed patients with acromegaly"],"prefix":"10.1111","volume":"75","author":[{"given":"Z.","family":"Karaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tanriverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Elbuken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Donmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Selcuklu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Durak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"Dokmetas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Colak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Unluhizarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kelestimur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,4]]},"reference":[{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","article-title":"Guidelines for acromegaly management: an update","volume":"94","author":"Melmed","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"c4189","DOI":"10.1136\/bmj.c4189","article-title":"Acromegaly","volume":"341","author":"Reddy","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1210\/jc.2002-021822","article-title":"Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission","volume":"88","author":"De","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1210\/jc.86.4.1645","article-title":"Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity","volume":"86","author":"Kaltsas","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000095533","article-title":"Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations","volume":"83","author":"Ludecke","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/eje.1.01863","article-title":"The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u2018cure\u2019","volume":"152","author":"Nomikos","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/jc.2005-2110","article-title":"Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients","volume":"91","author":"Colao","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2265.2008.03441.x","article-title":"Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study","volume":"70","author":"Colao","year":"2009","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1210\/jc.2005-2347","article-title":"Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage","volume":"91","author":"Cozzi","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2265.2007.02878.x","article-title":"Long-term (up to 18\u2003years) effects on GH\/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa","volume":"67","author":"Maiza","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/eje.1.02036","article-title":"Consensus statement: medical management of acromegaly","volume":"153","author":"Melmed","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2265.2007.02825.x","article-title":"A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly","volume":"66","author":"Mercado","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1210\/jc.2001-012012","article-title":"Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size","volume":"87","author":"Bevan","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2265.2006.02467.x","article-title":"First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial","volume":"64","author":"Colao","year":"2006","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1210\/jc.87.7.3013","article-title":"Somatostatin analogs in acromegaly","volume":"87","author":"Freda","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/BF03349263","article-title":"Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults","volume":"31","author":"Giustina","year":"2008","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-08-0267","article-title":"A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly","volume":"159","author":"Holdaway","year":"2008","journal-title":"European Journal of Endocrinology"},{"issue":"7 Suppl","key":"10.1111\/j.1365-2265.2011.04106.x-BIB18|cit18","first-page":"48","article-title":"Dynamic testing in the diagnosis and follow-up of patients with acromegaly","volume":"26","author":"Wass","year":"2003","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2265.2002.01597.x","article-title":"Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties","volume":"57","author":"Webb","year":"2002","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2265.2004.01992.x","article-title":"Efficacy of Sandostatin LAR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and\/or radiotherapy","volume":"60","author":"Ayuk","year":"2004","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1210\/jc.86.6.2779","article-title":"Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly","volume":"86","author":"Colao","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/EJE-07-0383","article-title":"Beneficial effect of dose escalation of octreotide-LAR as first-line therapy in patients with acromegaly","volume":"157","author":"Colao","year":"2007","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1210\/jc.2005-0260","article-title":"Long-acting somatostatin analog therapy of acromegaly: a meta-analysis","volume":"90","author":"Freda","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2265.2005.02317.x","article-title":"Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution","volume":"63","author":"Jallad","year":"2005","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/EJE-08-0498","article-title":"Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register","volume":"159","author":"Petersenn","year":"2008","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1210\/jc.2008-1420","article-title":"Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues","volume":"94","author":"Sherlock","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1210\/jc.2003-030110","article-title":"Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?","volume":"88","author":"Cozzi","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"Suppl 1","key":"10.1111\/j.1365-2265.2011.04106.x-BIB28|cit28","first-page":"S17","article-title":"Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly","volume":"155","author":"Wass","year":"1997","journal-title":"Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2265.2007.03012.x","article-title":"Wide variation in surgical outcomes for acromegaly in the UK","volume":"68","author":"Bates","year":"2008","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1210\/jc.86.9.4072","article-title":"Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria","volume":"86","author":"Kreutzer","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"Suppl 3","key":"10.1111\/j.1365-2265.2011.04106.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000023538","article-title":"Pituitary surgery for the management of acromegaly","volume":"53","author":"Laws","year":"2000","journal-title":"Hormone Research"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1210\/jc.82.10.3308","article-title":"Effect of octreotide pretreatment on surgical outcome in acromegaly","volume":"82","author":"Colao","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB33|cit33","first-page":"765","article-title":"Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR","volume":"18","author":"Lundin","year":"1997","journal-title":"AJNR. American Journal of Neuroradiology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-2265.2008.03270.x","article-title":"Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients","volume":"69","author":"Ronchi","year":"2008","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1210\/jc.2008-2627","article-title":"Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-month study","volume":"94","author":"Colao","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/jc.2008-1546","article-title":"Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study","volume":"94","author":"Colao","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB37|cit37","first-page":"610","article-title":"Thyrotropin-secreting pituitary tumors","volume":"17","author":"Beck-Peccoz","year":"1996","journal-title":"Endocrine Reviews"},{"key":"10.1111\/j.1365-2265.2011.04106.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1210\/jc.2008-0424","article-title":"Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months","volume":"93","author":"Colao","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2011.04106.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2265.2011.04106.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T17:51:20Z","timestamp":1625421080000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2011.04106.x"}},"subtitle":["Primary medical treatment and surgery in acromegaly"],"short-title":[],"issued":{"date-parts":[[2011,10,4]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04106.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13110956.14434054","asserted-by":"object"}]},"ISSN":["0300-0664"],"issn-type":[{"value":"0300-0664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,4]]}}}